Savant Capital, LLC Standard Biotools Inc. Put Options Transaction History
Savant Capital, LLC
- $13.2 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LAB
# of Institutions
151Shares Held
280MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$82.2 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$63.3 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$23.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$18.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$11.6 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $84.9M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...